Erythropoietin: from hematopoiesis to cardioprotection

Cardiovasc Drugs Ther. 2005 Jan;19(1):7-8. doi: 10.1007/s10557-005-6891-5.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Cardiotonic Agents* / metabolism
  • Cardiotonic Agents* / pharmacology
  • Cardiotonic Agents* / therapeutic use
  • Erythropoietin* / metabolism
  • Erythropoietin* / pharmacology
  • Erythropoietin* / therapeutic use
  • Hematopoiesis / drug effects*
  • Humans
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / metabolism
  • Receptors, Erythropoietin / metabolism
  • Recombinant Proteins

Substances

  • Cardiotonic Agents
  • Receptors, Erythropoietin
  • Recombinant Proteins
  • Erythropoietin